BF.B
48
-2
CSCO
64
6
ACN
56
2
CNP
49
-6
CMS
60
-2
AVGO
54
12
ABBV
59
13
BA
47
4
CF
48
4
ALLE
44
3
AEE
51
-7
CA
30
3
CNX
49
3
AN
50
7
AEP
61
-3
CMA
70
5
CL
58
2
AKAM
64
2
CFG
95
2
AME
72
6
BF.B
48
-2
CSCO
64
6
ACN
56
2
CNP
49
-6
CMS
60
-2
AVGO
54
12
ABBV
59
13
BA
47
4
CF
48
4
ALLE
44
3
AEE
51
-7
CA
30
3
CNX
49
3
AN
50
7
AEP
61
-3
CMA
70
5
CL
58
2
AKAM
64
2
CFG
95
2
AME
72
6
Financhill
Back

Transat A.T., Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
34

TRZ.TO
Transat A.T., Inc.

Last Price:
$2.63
Seasonality Move:
5.11%
Sell
18

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
34
Transat A.T., Inc. (TRZ.TO) is a Sell

Is Transat A.T., Inc. a Buy, Sell or Hold?

  • The current Transat A.T., Inc. [TRZ.TO] share price is $2.52. The Score for TRZ.TO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • TRZ.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TRZ.TO Stock Price Chart

What is Transat A.T., Inc.'s stock price today?

  • The Transat A.T., Inc. share price today is $2.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRZ.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

TRZ.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.36 Buy
Relative Strength Index (14 RSI): 53.97 Buy
Chaikin Money Flow: -38991 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

TRZ.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.58 Sell
20-day SMA: 2.45 Buy
50-day SMA: 2.33 Buy
200-day SMA: 2.23 Buy
8-day EMA: 1 Buy
20-day EMA: 0.46 Buy
50-day EMA: 0.2 Buy
200-day EMA: 0.05 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Transat A.T., Inc. Earnings Growth & TRZ.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.71 per share, and an increase next year of $1.23 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Transat A.T., Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):